Media

Press Articles

Press Article	Link	Date	Publication	Short Description
Ashi Anand ET Now Interview	Link	22-Aug-2023	ET Now	Ashi Anand discusses the market outlook, China slowdown, merits of digital platforms, and the opportunity in defence
Are new age platform stocks worthy of long-term investments? Ashi Anand answers	Link	22-Aug-2023	ET Now	Platform companies have the potential to compound revenues at over 25% in the long term. However, there is a misunderstanding about the profitability of these companies in the listed market space. Anand states that the current expenses are short-term and primarily linked to the current hyper growth phase. As these companies evolve and change consumer behavior, they can reduce costs and introduce monetization strategies.
Rajesh Pherwani discusses Top sectors that PMS managers bet for higher returns	Link	21-Aug-2023	Moneycontrol	Valcreate Lifesciences and Valcreate-IME Digital Disruption among top-3 PMS strategies in Healthcare and Consumer services respectively with top holdings.
Rajesh Pherwani on Reliance Life Sciences	Link	1-Aug-2023	Business Today	Why Reliance Life Sciences could be the next big thing in India's biotechnology space
Markets could remain range-bound over the coming year	Link	24-Jul-2023	ET Now	Ashi discusses the market outlook, digital platforms and FII flows
Ashi Anand on ET Now on Digital Stocks	Link	23-Jul-2023	ET Now	Ashi discusses consumption themes, digital platforms and market outlook
PMS Performance dazzles the Street	Link	17-Jul-2023	Moneycontrol	Article discusses the strong performance of Digital Disruption.
Investing in PSU Banks and Housing Finance Companies	Link	3-Jul-2023	Zee Business	Rajesh Pherwani discusses his views on investing in PSU banks and housing finance companies in his latest interview
Market Outlook - May 2023	Link	24-May-2023	Zee Business	Bullish on housing finance, home improvement companies... KNR Construction's favorite share: Rajesh Pherwani, Founder, Valcreate Investment Managers.
Why is Temasek-Manipal Health Enterprises deal 'premium'?	Link	8-Apr-2023	Business Today	Rajesh Pherwani decodes Temasek's majority stake acquisition in Manipal Health Enterprises at a valuation of Rs 40,000 crore
The pharma sector presents a study in contrast; here's why	Link	11-Dec-2022	BT500	Rajesh Pherwani's outlook for Pharma for the current year
With Covid gone as a money spinner, what are companies like Cipla, Sun Pharma and Dr Reddy's looking at?	Link	23-Oct-22	Business Today	Rajesh Pherwani sharing his views about the potential of pharma CDMO industry
Biocon’s subsidiary Syngene's shares drop 12% in 2022; here's what management and analysts have to say	Link	30-Sep-22	Business Today	Rajesh Pherwani talks about Syngene's contract research business
Article on Alkyl Amines in Business Today Magazine	Link	Mar 22 edition	Business Today Magazine	Excerpt of Rajesh Pherwani's views, on Alkyl Amines
Outsourcing opportunity for Indian Pharma and Speciality Chemical	Link1 Link2 Link3	28-Feb-2022	Brokers Forum of India Magazine - March 2022 edition	Article written by Rajesh Pherwani published in the Brokers Forum of India Magazine - March 2022 edition
Look what clicked for the PMSes that made big money since last Diwali	Link	11-Nov-2020	Economic Times	Economic Times coverage of Valcreate's leading performance
Six-month report cards show PMSes making dollops of money for ultra-HNIs	Link	13-Oct-2020	Economic Times	Economic Times coverage of Valcreate's leading performance
42 stocks from 2 sectors that doubled money in 2020 still have more steam	Link	23-Sept-2020	Economic Times	Economic Times coverage of Valcreate's leading performance
In one year until August 31, 3 of 4 PMSes beat Nifty index, says PMS Bazaar	Link	23-Sept-2020	CNBC TV18	CNBC TV18's coverage of Valcreate's leading performance
Three Fourths of PMS strategies beat returns of 2.8% by Nifty50 in August	Link	12-Sept-2020	Business Standard	Business Standard's coverage of Valcreate's leading performance
PMS schemes gain in June; 70% beat Nifty over one year, shows data	Link	14-July-2020	Business Standard	Business Standard's coverage of Valcreate's leading performance
PMSes deliver over 50% return for Q1, but a few high-profile ones lag	Link	14-July-2020	Economic Times	Economic Times coverage of Valcreate's leading performance
PMS investors that braved March massacre get up to 56% in Apr-June; 1 year gains as high as 36%	Link	14-July-2020	PMS Bazaar	PMS Bazaar's coverage of Valcreate's leading performance
Not a rich deal! Woes spilled over for most PMS alpha chasers in May	Link	13-June-2020	Economic Times	Economic Times coverage of Valcreate's leading performance
Average returns of PMSes outperform Benchmarks in May-2020	Link	13-June-2020	PMS Bazaar	PMS Bazaar's coverage of Valcreate's leading performance
When Valuations Are 40-50 Times P/E, Margin Of Error Is Very Small	Link	30-Jan-2020	The Finapolis	Rajesh Pherwani's views about company valuations
Banking sector to report good growth this earnings season, says Valcreate Investment Managers	Link	17-July-2019	CNBC TV18	CNBC TV18's coverage of Valcreate's leading performance
What Lies Ahead For Investors	Link	28-June-2019	Business Today	Rajesh Pherwani talks about the strong outlook for the Indian economy